A proibição da talidomida no eritema nodoso hansênico
DOI:
https://doi.org/10.47878/hi.2000.v25.36432Resumen
.
Descargas
Los datos de descargas todavía no están disponibles.
Citas
1 . BA RBA RUBIO, J ; FRANCO GONZA LE Z, E L u p u s eritematosos discoide y talidomida. Dermatologia - Rev. Mex., v.19, p.131, 1975.
2. BARNHILL, R.L.; McDOUGALL, A.C. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J. Amer. Acad. DermatoL, v.7, p.317-323, 1982.
3. GRINSPAN, D. Significant response of oral aphthosis to thalidomide treatment. J. Amer. Acad. DermatoL, v.12, p.85-90, 1985.
4. GROSSHANS, E.; ILLY, G. Thalidomide therapy for inflammatory dermatoses. Int. J. DermatoL, v.23, p.598602, 1984.
5. HASPER, M. Chronic cutaneous lupus erythematosus: thalidomide treatment of 11 patients. Arch. DermatoL, v.119, p.812-815, 1983.
6. MARWICK, C. A talidomida está de volta - sob rígido controle. JAMA, v.2, n.2, p.290, 1998.
7. PENNA, GO, PINHEIRO, A.M.C., HAJJAR, L.A. Talidomida: mecanismo de ação, efeitos colaterais e uso terapêutico. An. bras. Dermatol., v.73, n.6, p.501-514, 1998.
8. PROENÇA, N.G. Emprego de talidomida em dermatologia. An. bras. DermatoL, v.70, n.1, p.61-67, 1995.
9. RUSTIN, M.H.A.; GILKES, J.J.H.; ROBINSON, T.W.E. Pyoderma gangrenosum associated with Behçet's disease: treatment with thalidomide. J. Amer. Acad. DermatoL, v.23, p.941-943, 1990.
10. SHESKIN, J. Thalidomide in the treatment of lepra reactions. Clin. PharmacoL Ther., v.6, p.303, 1965.
11. THOMPSON, C. Thalidomide effective for AIDS related oral ulcers (news). Lancet, v.346, p.1289, 1995.
12. VAN DEN BROECK, H. Treatment of prurigo nodularis with thalidomide. Arch. Dermatol, v.116, p.571-572, 1980
2. BARNHILL, R.L.; McDOUGALL, A.C. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J. Amer. Acad. DermatoL, v.7, p.317-323, 1982.
3. GRINSPAN, D. Significant response of oral aphthosis to thalidomide treatment. J. Amer. Acad. DermatoL, v.12, p.85-90, 1985.
4. GROSSHANS, E.; ILLY, G. Thalidomide therapy for inflammatory dermatoses. Int. J. DermatoL, v.23, p.598602, 1984.
5. HASPER, M. Chronic cutaneous lupus erythematosus: thalidomide treatment of 11 patients. Arch. DermatoL, v.119, p.812-815, 1983.
6. MARWICK, C. A talidomida está de volta - sob rígido controle. JAMA, v.2, n.2, p.290, 1998.
7. PENNA, GO, PINHEIRO, A.M.C., HAJJAR, L.A. Talidomida: mecanismo de ação, efeitos colaterais e uso terapêutico. An. bras. Dermatol., v.73, n.6, p.501-514, 1998.
8. PROENÇA, N.G. Emprego de talidomida em dermatologia. An. bras. DermatoL, v.70, n.1, p.61-67, 1995.
9. RUSTIN, M.H.A.; GILKES, J.J.H.; ROBINSON, T.W.E. Pyoderma gangrenosum associated with Behçet's disease: treatment with thalidomide. J. Amer. Acad. DermatoL, v.23, p.941-943, 1990.
10. SHESKIN, J. Thalidomide in the treatment of lepra reactions. Clin. PharmacoL Ther., v.6, p.303, 1965.
11. THOMPSON, C. Thalidomide effective for AIDS related oral ulcers (news). Lancet, v.346, p.1289, 1995.
12. VAN DEN BROECK, H. Treatment of prurigo nodularis with thalidomide. Arch. Dermatol, v.116, p.571-572, 1980
Descargas
Publicado
2000-11-30
Cómo citar
1.
Opromolla DVA. A proibição da talidomida no eritema nodoso hansênico. Hansen. Int. [Internet]. 30 de noviembre de 2000 [citado 10 de mayo de 2024];25(2):111-2. Disponible en: https://periodicos.saude.sp.gov.br/hansenologia/article/view/36432
Número
Sección
Editorial
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Esta revista tiene la licencia Creative Commons Attribution 4.0 International License.
